Thyroid gland carcinoma
MONDO:0015075A carcinoma arising from the thyroid gland. It is usually an adenocarcinoma and includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic.
Also known as: cancer of the thyroid, cancer of thyroid, head and neck cancer, thyroid, thyroid cancer, thyroid gland cancer, carcinoma of the thyroid, carcinoma of the thyroid gland, carcinoma of thyroid
2978 clinical trials for this condition and its sub-types, 41 tagged with Thyroid gland carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Thyroid gland carcinoma
-
Differentiated thyroid carcinoma 79 trials · 182 incl. sub-types
3 sub-types
- Thyroid gland follicular carcinoma 20 trials · 77 incl. sub-types Sub-types →
- Thyroid gland papillary carcinoma 59 trials · 60 incl. sub-types Sub-types →
- Familial papillary or follicular thyroid carcinoma 1 trial · 13 incl. sub-types Sub-types →
-
Thyroid gland adenocarcinoma 0 trials · 118 incl. sub-types
3 sub-types
- Thyroid gland follicular carcinoma 20 trials · 77 incl. sub-types Sub-types →
- Thyroid gland papillary carcinoma 59 trials · 60 incl. sub-types Sub-types →
- Thyroid gland mucoepidermoid carcinoma 0 trials
-
Multiple endocrine neoplasia type 2 4 trials · 30 incl. sub-types
3 sub-types
- Familial medullary thyroid carcinoma 23 trials
- Multiple endocrine neoplasia type 2A 4 trials
- Multiple endocrine neoplasia type 2B 2 trials
-
Familial nonmedullary thyroid carcinoma 3 trials · 15 incl. sub-types
3 sub-types
- Familial papillary or follicular thyroid carcinoma 1 trial · 13 incl. sub-types Sub-types →
- Thyroid cancer, nonmedullary, 1 1 trial
- Familial papillary thyroid carcinoma with renal papillary neoplasia 0 trials
-
Intrathyroid thymic carcinoma 0 trials
-
Thyroid gland mucinous carcinoma 0 trials
Most studied deeper sub-types
-
New cocktail of cancer drugs tested in desperate cases
Disease control Stopped earlyThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Pazopanib dose hunt in frail seniors halted early
Disease control Stopped earlyThis phase 1 study tested the cancer drug pazopanib in 18 frail elderly patients (aged 75+) with metastatic cancers like kidney, lung, or breast cancer. The goal was to find the highest safe dose by starting at 400 mg daily and increasing if tolerated. The study was terminated ea…
Phase 1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Experimental cancer pill targets Hard-to-Treat gene mutations
Disease control Stopped earlyThis early study tested an experimental oral drug called IK-595 in people with advanced solid tumors that have specific RAS or RAF gene mutations. The goal was to check safety, dosing, and early signs of tumor shrinkage. The study was terminated before completion, so full results…
Phase 1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated Jun 26, 2026 19:17 UTC